Basic Information
LncRNA/CircRNA Name | MALAT1 |
Synonyms | MALAT1, HCN, LINC00047, NCRNA00047, NEAT2, PRO2853 |
Region | GRCh38_11:65497688-65506516 |
Ensemble | ENSG00000251562 |
Refseq | NR_002819 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 |
Methods | qPCR, Luciferase reporter assay, Western blot |
Sample | hepatocellular carcinoma tissues, cell lines (Huh-6, HepG2, SMMC-7721, Bel-7402, LO2) |
Expression Pattern | up-regulated |
Function Description | MALAT1 was upregulated in HCC tissues. ZEB1 was a target of miR-143-3p. miR-143-3p binds with MALAT1, and was regulated by MALAT1.The regulation of MALAT1 on ZEB1 was mediated by miR-143-3p. MALAT1 may regulate ZEB1 expression by sponging miR-143-3p and promotes hepatocellular carcinoma progression.the patients with higher MALAT1 expression had poor overall survival. |
Pubmed ID | 28543721 |
Year | 2017 |
Title | Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression. |
External Links
Links for MALAT1 | GenBank HGNC NONCODE |
Links for hepatocellular carcinoma | OMIM COSMIC |